Critical Comparison: NeuroOne Medical Technologies (NASDAQ:NMTC) and Odyssey Health (OTCMKTS:ODYY)

Odyssey Health (OTCMKTS:ODYY) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, profitability, valuation and risk.

Institutional and Insider Ownership

16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 7.5% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Odyssey Health and NeuroOne Medical Technologies’ top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Odyssey Health	N/A	N/A	N/A	N/A	N/A
NeuroOne Medical Technologies	$3.73 million	5.54	-$11.86 million	($0.58)	-1.28

Odyssey Health has higher earnings, but lower revenue than NeuroOne Medical Technologies.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Odyssey Health and NeuroOne Medical Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Odyssey Health	0	0	0	0	N/A
NeuroOne Medical Technologies	0	0	1	0	3.00

NeuroOne Medical Technologies has a consensus target price of $2.20, indicating a potential upside of 196.90%. Given NeuroOne Medical Technologies’ higher probable upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Odyssey Health.

Profitability

This table compares Odyssey Health and NeuroOne Medical Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Odyssey Health	N/A	N/A	N/A
NeuroOne Medical Technologies	-343.55%	-277.71%	-204.28%

Summary

NeuroOne Medical Technologies beats Odyssey Health on 5 of the 8 factors compared between the two stocks.

About Odyssey Health

Odyssey Health, Inc., a medical company, focuses on the development and commercialization of medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and ONP -001 and ONP -002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.